Study Of 215 Patients Who Required High Flow Nasal Cannula During Corona Virus Epidemic
Study Of 215 Patients Who Required High Flow Nasal Cannula During Corona Virus Epidemic
DOI:
https://doi.org/10.70284/njirm.v13i1.3401Keywords:
High Flow Nasal Cannula Therapy, Acute Respiratory Failure, Co-MorbiditiesAbstract
Background: High flow nasal cannula is a newer modality of treatment for hypoxemic respiratory failure. Present study is conducted to evaluate demographic characteristics, co-morbidities and outcome parameters of patients on High flow nasal cannula. Material And Methods: In retrospective observational study all patients on High flow nasal canula with covid-19 were evaluated for demographic characteristics and outcome with comorbidities during study period. Result: Maximum number of patients belongs to age group 51-60 years. Highest mortality was in the age group of 61-70 years. Conclusion: The High flow nasal cannula therapy may provide important newer modality and helpful in patients with respiratory failure. [Shah V Natl J Integr Res Med, 2022; 13(1): 61-63, Published on 26/01/2022]